Literature DB >> 3512731

Extraintestinal Campylobacter jejuni and Campylobacter coli infections: host factors and strain characteristics.

M J Blaser, G P Perez, P F Smith, C Patton, F C Tenover, A J Lastovica, W I Wang.   

Abstract

To determine whether extraintestinal isolates of Campylobacter jejuni and Campylobacter coli are the consequence of unusual host or bacterial characteristics, we studied clinical and bacteriologic features of 24 extraintestinal infections. Common serotypes and auxotypes were present among the extraintestinal isolates. Gastrointestinal isolates were more susceptible to normal human serum than were the systemic isolates; however, the ranges overlapped considerably. Predispositions to systemic spread were present in 52% of patients with extraintestinal infections; isolates from these patients were more often (73%) serum sensitive than were isolates from patients without predispositions (9%; P = .002). By sodium dodecyl sulfate-polyacrylamide gel electrophoresis, no specific protein band was associated with serum resistance, and all isolates of C. jejuni and C. coli had rough-type lipopolysaccharide profiles. Serum susceptibility was inversely correlated with carbohydrate or ketodeoxyoctonate (KDO) fraction of cell weight and directly correlated with KDO:carbohydrate ratio. Our results suggest that either host defects or specific bacterial virulence characteristics, such as serum resistance, possibly related to length of lipopolysaccharide side chain, may be responsible for extraintestinal infections due to C. jejuni and C. coli.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3512731     DOI: 10.1093/infdis/153.3.552

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  41 in total

1.  Characterization of high-level quinolone resistance in Campylobacter jejuni.

Authors:  T D Gootz; B A Martin
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

2.  Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter sp. cdtB gene.

Authors:  C L Pickett; E C Pesci; D L Cottle; G Russell; A N Erdem; H Zeytin
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

3.  Bacteremia caused by Arcobacter cryaerophilus 1B.

Authors:  P R Hsueh; L J Teng; P C Yang; S K Wang; S C Chang; S W Ho; W C Hsieh; K T Luh
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

Review 4.  Global Epidemiology of Campylobacter Infection.

Authors:  Nadeem O Kaakoush; Natalia Castaño-Rodríguez; Hazel M Mitchell; Si Ming Man
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

5.  Campylobacter jejuni isolations from Mexican and Swedish patients, with repeated symptomatic and/or asymptomatic diarrhoea episodes.

Authors:  E Sjögren; G Ruiz-Palacios; B Kaijser
Journal:  Epidemiol Infect       Date:  1989-02       Impact factor: 2.451

6.  Ultrastructure of Campylobacter jejuni in gamma-irradiated mouse jejunum.

Authors:  L Sosula; E M Nicholls; M Skeen
Journal:  Am J Pathol       Date:  1988-04       Impact factor: 4.307

7.  Septic abortion due to Campylobacter jejuni.

Authors:  M Moscuna; Z Gross; R Korenblum; M Volfson; M Oettinger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

8.  Experimental Campylobacter jejuni infection in Macaca nemestrina.

Authors:  R G Russell; M J Blaser; J I Sarmiento; J Fox
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

9.  Use of an immunoglobulin M containing preparation for treatment of two hypogammaglobulinemic patients with persistent Campylobacter jejuni infection.

Authors:  J C Borleffs; J F Schellekens; E Brouwer; M Rozenberg-Arska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

10.  Naturally occurring auxotrophs of Campylobacter jejuni and Campylobacter coli.

Authors:  F C Tenover; C M Patton
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.